Results 201 to 210 of about 1,197,543 (390)
RADIOACTIVE IRON ABSORPTION IN CLINICAL CONDITIONS: NORMAL, PREGNANCY, ANEMIA, AND HEMOCHROMATOSIS [PDF]
, 1942 William M. Balfour +4 more
openalex +1 more source
Salvage Trans‐Sylvian Peri‐Insular Hemispherotomy After Embolic Hemispherectomy
Annals of the Child Neurology Society, EarlyView.ABSTRACT Background Hemispherectomy and hemispherotomy represent well‐established treatments for drug‐resistant hemispheric epilepsy. An alternative endovascular procedure has been explored for cases with challenging surgical anatomy, which seeks to achieve the clinical effect of hemispherectomy via embolization of the major cerebral arteries and ...
Michael E. Baumgartner +4 more
wiley +1 more source
NefrologíaResumen: Los inhibidores del cotransportador sodio-glucosa tipo 2 (iSGLT2) han demostrado su beneficio cardiovascular y renal en pacientes con diabetes mellitus tipo 2, insuficiencia cardiaca (IC) o enfermedad renal crónica (ERC).
Aleix Cases +3 more
doaj
Evaluation of Splenectomy in the Treatment of Cooleyʼs Anemia
, 1958 Robert A. Mainzer, Walter J. OʼConnor
openalex +2 more sources
BRAIN CHANGES ASSOCIATED WITH PERNICIOUS ANEMIA [PDF]
, 1918 Henry W. Woltman
openalex +1 more source
Clinical Pharmacology in Drug Development, EarlyView.Abstract This study (NCT04537715) investigated itraconazole (strong cytochrome P450 [CYP] 3A inhibitor) and rifampin (strong CYP3A inducer) on tazemetostat pharmacokinetics. In Part 1, patients received tazemetostat 400 mg orally on Days 1, 15, and 36, and 400 mg twice daily on Days 3‐14 and Days 21‐35.
Yingxue Chen +6 more
wiley +1 more source
Clinical Pharmacology in Drug Development, EarlyView.Abstract Berzosertib is a small‐molecule ataxia telangiectasia and Rad3‐related protein inhibitor. To assess the clearance mechanism(s) of berzosertib, a Phase 1, 2‐period, open‐label study was conducted in adults with advanced solid tumors who were treated with a single intravenous dose of 210 mg/m2 berzosertib containing approximately 3 µCi of [14C ...
Jayaprakasam Bolleddula +12 more
wiley +1 more source
Development of Interarterial Coronary Anastomoses by Chronic Anemia. Disappearance Following Correction of Anemia [PDF]
, 1955 RICHARD W. ECKSTEIN
openalex +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.In pediatric oncology, pharmacogenetic guidelines are underutilized and the potential impact of pre‐emptive pharmacogenetic screening remains largely unexplored despite this field's need for individualized approaches. While comprehensive pharmacogenetic guidelines are not yet available for all anticancer drugs, evidence‐based recommendations exist for ...
Emma C. Bernsen +12 more
wiley +1 more source
Reticulocytopenia in Autoimmune Hemolytic Anemia [PDF]
, 1956 William H. Crosby, Henry Rappaport
openalex +1 more source